EXECUTIVE BOARD 121st Session Provisional agenda item 6.5
EB121/8 Add.1 24 May 2007
Report on financial and administrative implications for the Secretariat of resolutions proposed for adoption by the Executive Board or Health Assembly 1. Resolution Expert Committee on the Selection and Use of Essential Medicines: establishment of a subcommittee 2. Linkage to programme budget Biennium 2006–2007 Area of work: Essential medicines Expected result 7. Awareness raising and guidance on cost-effective and sound use of medicines promoted, with a view to improving use of medicines by health professionals and consumers.
Biennium 2008–2009 Strategic objective: 11 3. Evidence-based policy guidance on promoting scientifically sound and cost-effective use of medical products and technologies by health workers and consumers developed and supported within the Secretariat and regional and national programmes.
3. Financial implications (a) Total estimated cost for implementation over the “life-cycle” of the resolution (estimated to the nearest US$ 10 000, including staff and activities) US$ 450 000 (b) Estimated cost for the biennium 2006–2007 (estimated to the nearest US$ 10 000, including staff and activities) US$ 180 000 (c) Of the estimated cost noted in (b), what can be subsumed under existing programmed activities? 100%
EB120/8 Add.1
4. Administrative implications (a) Implementation locales (indicate the levels of the Organization at which the work will be undertaken and identify the specific regions where relevant) Normative work to be undertaken at headquarters. Consultation with regions and countries required. (b) Additional staffing requirements (indicate additional required staff full-time equivalents, noting necessary skills profile) The equivalent of one full-time staff member in the professional category will be required for the biennium 2008–2009. (c) Time frames (indicate broad time frames for implementation and evaluation) Development of a list of essential medicines for children during the period 2007–2008; and dissemination and consultation leading to endorsement in 2009 by the Expert Committee on the Selection and Use of Essential Medicines. It is anticipated that the subcommittee will be disbanded at that time.
=
=
=
2